Winter 2006

New Catheter Laboratories Extend the Reach of Cardiologists

UCSF has recently celebrated the opening of two advanced catheter laboratories that will provide cardiologists with some of the finest facilities in California, physicians say. The completion of the catheter laboratories marks the first phase of a three-phase project to build the new UCSF Heart and Vascular Center.

The two laboratories are state-of-the-art Philips labs. The new electrophysiology laboratory is the first catheter stereotaxis facility in California with a magnetic guidance system. The system moves the catheter to a precise location in the heart and holds it there using magnets. The system should reduce by half the time needed for procedures like mapping.

The second and third phases of the Heart and Vascular Center at UCSF will be the completion of an outpatient diagnostic center and an inpatient diagnostic center.

To learn more about the catheter labs, contact Karen Rago, administrative director of the UCSF Heart and Vascular Center at (415) 476-0796.

Related Information

News Releases

Steroids Increase Heart Attack and Liver Damage
Anabolic steroid use causes decreased levels of HDL, increased levels of LDL and serious liver toxicity within 12 weeks, according to a study that measured the effects of anabolic steroids on men with HIV wasting disease.

System Predicts Mortality of Older Americans
Researchers at the San Francisco VA Medical Center have created an index that is 81 percent accurate in predicting the likelihood of death within four years for people 50 and older.

Physician Experience Accurately Detects Third Heart Sound
Physicians with more experience are better able to detect a third heart sound that is an indicator of heart disease, according to a study on stethoscope accuracy in cardiac patients at UCSF Medical Center.

UCSF Heart Transplant Program Named Center of Excellence
The UCSF Heart and Vascular Center has been designated a center of excellence in heart transplants by Blue Cross and Blue Shield, both of California. The designations -- Blue Shield in January and Blue Cross in February -- were issued after a review of UCSF's heart transplant results and its performance against industry benchmarks.